Does RISANKIZUMAB-RZAA Cause Back pain? 819 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 819 reports of Back pain have been filed in association with RISANKIZUMAB-RZAA. This represents 1.3% of all adverse event reports for RISANKIZUMAB-RZAA.
819
Reports of Back pain with RISANKIZUMAB-RZAA
1.3%
of all RISANKIZUMAB-RZAA reports
6
Deaths
221
Hospitalizations
How Dangerous Is Back pain From RISANKIZUMAB-RZAA?
Of the 819 reports, 6 (0.7%) resulted in death, 221 (27.0%) required hospitalization, and 3 (0.4%) were considered life-threatening.
Is Back pain Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 819 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Back pain?
ADALIMUMAB (9,779)
ETANERCEPT (6,029)
EVOLOCUMAB (5,254)
METHOTREXATE (4,580)
LENALIDOMIDE (4,531)
DENOSUMAB (4,465)
SECUKINUMAB (4,161)
TERIPARATIDE (3,929)
TOFACITINIB (3,213)
RITUXIMAB (2,637)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Back pain Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA